- Open
- 2.65
- High
- 2.80
- Low
- 2.50
- Close
- 2.50
- Change
- -0.15 (-5.66%)
- Volume
- 923,498
⌘K
| 30 Apr 2026 | 07:00:06 | Final results for the year ended 31 December 2025 |
| 2 Apr 2026 | 07:00:03 | £250,000 Funding Facility |
| 23 Feb 2026 | 07:00:10 | Progress on Launch of Biomarker Test in USA |
| 4 Feb 2026 | 07:00:09 | Patent Granted in Canada |
| 1 Sep 2025 | Financial Statements for the year ended 31 December 2024 | |
| 8 Jul 2025 | Annual Report for the year ended 31 December 2024 | |
| 11 Jun 2024 | Cizzle Biotechnology Holdings plc - Final results for the year ended 31 December 2023 |
Cizzle Biotech received its initial funding from various sources including Yorkshire Cancer Research, White Rose Technology Seed Corn Fund, Finance Yorkshire Seedcorn LLP and Viking Members. The funds were invested in the project to aid the development of a prototype blood test, with the support of the management team.
| 30 Apr 2026 | 07:00:06 | Final results for the year ended 31 December 2025 |
| 2 Apr 2026 | 07:00:03 | £250,000 Funding Facility |
| 23 Feb 2026 | 07:00:10 | Progress on Launch of Biomarker Test in USA |
| 4 Feb 2026 | 07:00:09 | Patent Granted in Canada |
| 1 Sep 2025 | Financial Statements for the year ended 31 December 2024 | |
| 8 Jul 2025 | Annual Report for the year ended 31 December 2024 | |
| 11 Jun 2024 | Cizzle Biotechnology Holdings plc - Final results for the year ended 31 December 2023 |
Cizzle Biotech received its initial funding from various sources including Yorkshire Cancer Research, White Rose Technology Seed Corn Fund, Finance Yorkshire Seedcorn LLP and Viking Members. The funds were invested in the project to aid the development of a prototype blood test, with the support of the management team.
| 5 Nov 2025 | 07:01:01 | £250,000 Convertible Loan Note Issue |
| 1 Apr 2022 |
| April 2022 Monthly |
| 8 Feb 2022 | Strategic alliance in China |
| 7 Dec 2021 | News flow driven by deals |
| 30 Sept 2021 | Keeping on-track |
| 20 Sept 2021 | Strategic collaboration with SGSC |
| 14 May 2021 | Early detection of lung cancer |
| 5 Nov 2025 | 07:01:01 | £250,000 Convertible Loan Note Issue |
| 1 Apr 2022 |
| April 2022 Monthly |
| 8 Feb 2022 | Strategic alliance in China |
| 7 Dec 2021 | News flow driven by deals |
| 30 Sept 2021 | Keeping on-track |
| 20 Sept 2021 | Strategic collaboration with SGSC |
| 14 May 2021 | Early detection of lung cancer |
